How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing

Lancet

Volumn 353, Issue 9151, 1999, Pages 490-493

  Chalmers, Iain ^a   Altman, Douglas G ^b  

^a UK COCHRANE CENTRE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; ELECTRONICS; INFORMATION SYSTEM; INTERNET; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; PEER REVIEW; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZATION; SHORT SURVEY;

EID: 0033528213     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07618-1     Document Type: Note

References (59)

1. Chalmers I., Altman D.G. Systematic reviews. 1995;British Medical Journal, London.
2. Jadad A.R., Cook D.J., Jones A.et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA. 280:1998;278-280.
3. Soares K., McGrath J., Adams C. Evidence and tardive dyskinesia. Lancet. 347:1996;1696-1697.
4. Hotopf M., Lewis G., Normand C. Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health. 51:1997;354-358.
5. Schulz K, Chalmers I, Altman DG, Grimes DA, Doré CJ. The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online J Curr Clin Trials 1995 August 26; 4 (doc no 197); [81 paragraphs]. 2 figures; 16 tables.
6. Begg C., Cho M., Eastwood S.et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 276:1996;637-639.
7. Altman D.G. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 313:1996;570-571.
8. Altman D.G. The scandal of poor medical research. BMJ. 308:1994;283-284.
9. Silverman W.A., Altman D.G. Patients' preferences and randomised trials. Lancet. 347:1996;171-174.
10. McGuigan S.M. The use of statistics in the British Journal of Psychiatry. Br J Psychiatry. 167:1995;683-688.
11. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412.
12. Giammona M., Glantz S.A. Poor statistical design in research on humans: the role of committees on human research. Clin Res. 31:1984;472-478.
13. Newcombe R.G. Towards a reduction in publication bias. BMJ. 297:1987;656-659.
14. Kupfersmid J. Improving what is published: a model in search of an editor. Am Psychol. 43:1988;635-642.
15. Weiss D.J. An experiment in publication: advance publication review. Appl Psychol Meas. 13:1989;1-7.
16. Siegel J.P. Editorial review of protocols for clinical trials. N Engl J Med. 323:1990;1355.
17. Relman A.S. Editorial review of protocols for clinical trials. N Engl J Med. 323:1990;1355.
18. Foss A., Westcott M. Major journals should peer review trials at protocol stage. BMJ. 314:1997;1691.
19. BMJ Editor. Major journals should peer review trials at protocol stage (reply). BMJ 1997; 314: 1691-92.
20. 2-prophylaxis and volume substitution with Haemaccel-35 on cardiovascular and respiratory disturbances and histamine release: protocol of a controlled clinical trial. Theor Surg. 3:1988;55-77.
21. Pilz G., Fateh-Moghadam S., Viell B.et al. Supplemental immunoglobulin therapy in sepsis and septic shock - comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo: protocol of a multicentre, randomized, prospective, double-blind trial. Theor Surg. 8:1993;61-83.
22. Remy W., Rakoski J., Siebenwirth J., Ulm K., Wiesenauer M. Classical homeopathic treatment in atopic patients - protocol for a prospective randomized, placebo-controlled double-blind study. Allergologie. 18:1995;246-252.
23. Tsubono Y., Okubo S., Hayashi M., Kakizoe T., Tsugane S. A randomised controlled trial for chemoprevention of gastric cancer in high-risk Japanese population; study design, feasibility and protocol modification. Jpn J Cancer Res. 88:1997;344-349.
24. Erbel R., Dill T., Dietz U.et al. The comparison of balloon versus rotational angioplasty (COBRA) study protocol: a prospective randomized study. J Interventional Cardiol. 10:1997; 271-275.
25. Adams R.J., McKie V.C., Brambilla D.et al. Stroke prevention trial in sickle cell anemia. Controlled Clin Trials. 19:1998;110-129.
26. Spitzer W.O., Thorogood M., Heinemann L. Trinational case-control study of oral contraceptives and health. Pharmacoepidemiol Drug Safety. 2:1993;21-31.
27. Lewis M.A., Assmann A., Heinemann L., Spitzer W.O. Interim review of the transnational case-control study of oral contraceptives and health: approved protocol revisions through September 1995. Pharmacoepidemiol Drug Safety. 5:1996;43-51.
28. Gueyffier F., Bottacchi E., Beghi E.et al. A case-control study on alcohol and seizures: study design, protocol, and data collection. The ALCE (Alcohol and Epilepsy) Study Group. Ital J Neurol Sci. 18:1997;119-124.
29. Gueyffier F., Boutitie F., Boissel J.P.et al. INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. Thérapie. 50:1995;353-362.
30. Downs J.R., Gotto A., Clearfield M.et al. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Am J Cardiol. 75:1995;1130-1134.
31. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. J Hypertens. 16:1998;127-137.
32. Simes R.J. Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) Project and the Cholesterol Treatment Trialists (CTT Collaboration). Am J Cardiol. 76:1995;122C-126C.
33. Spitzer W.O., Lewis M.A., Heinemann L.A.J., Thorogood M., MacRae K.D. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ. 312:1996;83-88.
34. Hobsley M., Moss J., Levi R., Clarke R.S.J., Fisher M.McD., Watkins J. Discussion forum about a protocol of a controlled clinical trial: induction of anaesthesia and perioperative risk. Theor Surg. 3:1988;132-151.
35. Lorenz W., Duda D., Dick W.et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet. 343:1994;933-940.
36. Lorenz W., Neugebauer E., Pilz G.et al. Discussion about the trial protocol of supplemental immunoglobulin therapy in sepsis and septic shock. Theor Surg. 9:1994;10-67.
37. The Cochrane Database of Systematic Reviews. In: the Cochrane Library. Issue 1. Oxford: Update Software, 1999.
38. Bero L. Electronic peer review of The Cochrane Database of Systematic Reviews. Paper presented at the Conference on Peer Review and Global Communications, Prague, 21 September 1997.
39. Horton R. Pardonable revisions and protocol reviews. Lancet. 349:1997;6.
40. McNamee D. Protocol reviews at The Lancet. Lancet. 350:1997;6.
41. Tramër M.R., Reynolds D.J.M., Moore R.A., McQuay H.J.Impact of covert duplicate publication on meta-analysis: a case-study BMJ. 315:1997;635-640.
42. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
43. Meinert C.L. Beyond CONSORT: need to improve reporting standards for controlled trials. JAMA. 279:1998;1487-1489.
44. Medical Research Council. MRC guidelines for good clinical practice in clinical trials. London: Medical Research Council, 1998.
45. Savulescu J., Chalmers I., Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ. 313:1996;1390-1393.
46. US Congress. Food and Drug Administration Modernization Act of 1997. See http://www.fda.gov/cder/guidance/105-115.htm .
47. Chollar S. A registry for clinical trials. Ann Intern Med. 128:1998;701-702.
48. Department of Health. National Research Register. Database on CD-ROM. Oxford: Update Software, 1998.
49. The Cochrane Controlled Trials Register. In: The Cochrane Library. Issue 1. Oxford: Update Software, 1999.
50. Moher D. CONSORT: and evolving tool to help improve the quality of reports of randomized controlled trials. JAMA. 279:1998;1489-1491.
51. Davey Smith G. Increasing the accessibility of data. BMJ. 308:1994;1519-1520.
52. Kirwan J.R. Making original data from clinical studies available for alternative analyses. J Rheumatol. 24:1997;822-825.
53. Bowie C. Was the paper I wrote a fraud? BMJ. 316:1998;175-176.
54. Delamothe T. Whose data are they anyway? BMJ. 312:1996;1241-1242.
55. Delamothe T., Smith R. The BMJ's website scales up. BMJ. 316:1998;1109-1110.
56. Butterworth I (ed). The impact of electronic publishing on the academic community. London: Portland Press, 1998 (available at http://www.portlandpress.co.uk/books/isbn/1855781220.htm ).
57. Wilkinson SL. Electronic publishing takes journals into a new realm. Chemical and Engineering News 1998, 18 May (available at http://pubs.acs.org/hotartcl/cenear/980518/elec.html ).
58. McConnell J., Horton R. Having electronic preprints is logical. BMJ. 315:1998;1907.
59. Smith R. What is publication? A continuum. BMJ. 318:1999;142.